Literature DB >> 26515625

Spinal and Bulbar Muscular Atrophy.

Christopher Grunseich1, Kenneth H Fischbeck2.   

Abstract

Spinal and bulbar muscular atrophy, or Kennedy disease, is a slowly progressive X-linked neuromuscular disease caused by a trinucleotide (CAG) repeat expansion in the androgen receptor gene. Affected males typically develop weakness in their mid-40s as well as evidence of androgen insensitivity with reduced fertility and gynecomastia. Diagnosis is often delayed because of decreased awareness of the disease, although genetic testing allows for direct diagnosis. Therapeutic strategies to block the toxicity of the mutant androgen receptor have been unsuccessful thus far, and evaluation of additional candidate therapies is underway. Published by Elsevier Inc.

Entities:  

Keywords:  Androgen receptor; Kennedy disease; Motor neuron disease; Spinal and bulbar muscular atrophy

Mesh:

Substances:

Year:  2015        PMID: 26515625      PMCID: PMC4628725          DOI: 10.1016/j.ncl.2015.07.002

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  42 in total

1.  Discrimination of spinal and bulbar muscular atrophy from amyotrophic lateral sclerosis using sensory nerve action potentials.

Authors:  Tetsuo Hama; Masaaki Hirayama; Takashi Hara; Tomohiko Nakamura; Naoki Atsuta; Haruhiko Banno; Keisuke Suzuki; Masahisa Katsuno; Fumiaki Tanaka; Gen Sobue
Journal:  Muscle Nerve       Date:  2012-02       Impact factor: 3.217

2.  Pilot trial of clenbuterol in spinal and bulbar muscular atrophy.

Authors:  Giorgia Querin; Carla D'Ascenzo; Enrico Peterle; Mario Ermani; Luca Bello; Paola Melacini; Lucia Morandi; Letizia Mazzini; Vincenzo Silani; Monika Raimondi; Jessica Mandrioli; Silvia Romito; Corrado Angelini; Elena Pegoraro; Gianni Sorarù
Journal:  Neurology       Date:  2013-05-03       Impact factor: 9.910

3.  Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients.

Authors:  Christopher Grunseich; Kristen Zukosky; Ilona R Kats; Laboni Ghosh; George G Harmison; Laura C Bott; Carlo Rinaldi; Ke-lian Chen; Guibin Chen; Manfred Boehm; Kenneth H Fischbeck
Journal:  Neurobiol Dis       Date:  2014-06-09       Impact factor: 5.996

4.  Expression of androgen receptor in X-linked spinal and bulbar muscular atrophy and amyotrophic lateral sclerosis.

Authors:  A Ogata; T Matsuura; K Tashiro; F Moriwaka; T Demura; T Koyanagi; K Nagashima
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-10       Impact factor: 10.154

5.  Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial.

Authors:  Lindsay E Fernández-Rhodes; Angela D Kokkinis; Michelle J White; Charlotte A Watts; Sungyoung Auh; Neal O Jeffries; Joseph A Shrader; Tanya J Lehky; Li Li; Jennifer E Ryder; Ellen W Levy; Beth I Solomon; Michael O Harris-Love; Alison La Pean; Alice B Schindler; Cheunju Chen; Nicholas A Di Prospero; Kenneth H Fischbeck
Journal:  Lancet Neurol       Date:  2011-01-06       Impact factor: 44.182

6.  Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial.

Authors:  Masahisa Katsuno; Haruhiko Banno; Keisuke Suzuki; Yu Takeuchi; Motoshi Kawashima; Ichiro Yabe; Hidenao Sasaki; Masashi Aoki; Mitsuya Morita; Imaharu Nakano; Kazuaki Kanai; Shoichi Ito; Kinya Ishikawa; Hidehiro Mizusawa; Tomotaka Yamamoto; Shoji Tsuji; Kazuko Hasegawa; Takayoshi Shimohata; Masatoyo Nishizawa; Hiroaki Miyajima; Fumio Kanda; Yasuhiro Watanabe; Kenji Nakashima; Akira Tsujino; Taro Yamashita; Makoto Uchino; Yasushi Fujimoto; Fumiaki Tanaka; Gen Sobue
Journal:  Lancet Neurol       Date:  2010-08-04       Impact factor: 44.182

7.  Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease).

Authors:  N Preisler; G Andersen; F Thøgersen; C Crone; T D Jeppesen; F Wibrand; J Vissing
Journal:  Neurology       Date:  2009-01-27       Impact factor: 9.910

8.  Standard and modified statistical MUNE evaluations in spinal-bulbar muscular atrophy.

Authors:  Tanya J Lehky; Cheun Ju Chen; Nicholas A di Prospero; Lindsay E Rhodes; Kenneth Fischbeck; Mary Kay Floeter
Journal:  Muscle Nerve       Date:  2009-11       Impact factor: 3.217

9.  Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy.

Authors:  Erica S Chevalier-Larsen; Christopher J O'Brien; Huiyi Wang; Shannon C Jenkins; Latia Holder; Andrew P Lieberman; Diane E Merry
Journal:  J Neurosci       Date:  2004-05-19       Impact factor: 6.167

10.  Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females.

Authors:  Gianni Sorarù; Carla D'Ascenzo; Alberto Polo; Arianna Palmieri; Linda Baggio; Lodovica Vergani; Cinzia Gellera; Giuseppe Moretto; Elena Pegoraro; Corrado Angelini
Journal:  J Neurol Sci       Date:  2007-09-12       Impact factor: 3.181

View more
  7 in total

Review 1.  Clinical and neuroimaging review of triplet repeat diseases.

Authors:  Ryo Kurokawa; Mariko Kurokawa; Akihiko Mitsutake; Moto Nakaya; Akira Baba; Yasuhiro Nakata; Toshio Moritani; Osamu Abe
Journal:  Jpn J Radiol       Date:  2022-09-28       Impact factor: 2.701

Review 2.  Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease.

Authors:  Marianthi Breza; Georgios Koutsis
Journal:  J Neurol       Date:  2018-07-13       Impact factor: 4.849

Review 3.  Can Proprioceptive Training Reduce Muscle Fatigue in Patients With Motor Neuron Diseases? A New Direction of Treatment.

Authors:  Ayman A Mohamed
Journal:  Front Physiol       Date:  2019-10-01       Impact factor: 4.566

4.  The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations.

Authors:  Pierre-François Pradat; Emilien Bernard; Philippe Corcia; Philippe Couratier; Christel Jublanc; Giorgia Querin; Capucine Morélot Panzini; François Salachas; Christophe Vial; Karim Wahbi; Peter Bede; Claude Desnuelle
Journal:  Orphanet J Rare Dis       Date:  2020-04-10       Impact factor: 4.123

5.  Clinical Phenotyping and Biomarkers in Spinal and Bulbar Muscular Atrophy.

Authors:  Elina Millere; Dmitrijs Rots; Ieva Glazere; Gita Taurina; Natalja Kurjane; Viktorija Priedite; Linda Gailite; Kaj Blennow; Henrik Zetterberg; Viktorija Kenina
Journal:  Front Neurol       Date:  2021-01-20       Impact factor: 4.003

6.  Mortality of 196,826 Men and Women Working in U.S.-Based Petrochemical and Refinery Operations: Update 1979 to 2010.

Authors:  Nancy C Wojcik; Elizabeth M Gallagher; Melannie S Alexander; R Jeffrey Lewis
Journal:  J Occup Environ Med       Date:  2022-03-01       Impact factor: 2.306

7.  Highly Elevated Prevalence of Spinobulbar Muscular Atrophy in Indigenous Communities in Canada Due to a Founder Effect.

Authors:  Jamie N Leckie; Matthew M Joel; Kristina Martens; Alexandra King; Malcolm King; Lawrence W Korngut; A P Jason de Koning; Gerald Pfeffer; Kerri L Schellenberg
Journal:  Neurol Genet       Date:  2021-07-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.